Montelukast Sodium
Product Images NDC 68151-4186

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 68151-4186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error Of The Mean) (Image 01)

The text is describing a graph that shows the change in height (measured in cm) over a period of 56 weeks, with weeks on treatment shown on the x-axis and the treatment groups shown on the y-axis. The treatment groups are Montelukast, Beciomethasone, and a placebo (with 120, 119, and 2121 participants, respectively). The text notes that the standard errors for the treatment group means in change in height are too small to be visible in the graph.*

FDA Label Image

Montelukast Sodium Structural Formula (Image 02)

FDA Label Image

Figure 2: Fev1 Mean Percent Change From Baseline (u.s. Trial: Montelukast Sodium N = 406; Placebo N = 270) (anova Model) (Image 03)

FDA Label Image

Label Image (Lbl681514186)

This is a description of a medicine called Montelukast Sodium, which comes in a chewable tablet form and contains 5mg of the active ingredient. The lot number is indicated as "65M035" and the expiration date is "06/16". The text also mentions a batch code "W1215159m16" and a note that the medicine is available only with a prescription (RX ONLY).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.